Zidovudine Alternatives Compared
Zidovudine | Biktarvy | Truvada |
|
---|
Zidovudine | Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | Truvada (emtricitabine / tenofovir) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Reduction of Perinatal Transmission of HIV, Occupational Exposure, HIV Infection, Nonoccupational Exposure. zidovudine may also be used for purposes not listed in this medication guide. View more |
Prescription only
Biktarvy is a combination tablet that contains three antiviral agents which may be used to treat HIV-1 in adults and children weighing more than 25kg (55lb). It is generally well-tolerated and the... View more |
Prescription only
Prescribed for Pre-Exposure Prophylaxis, Nonoccupational Exposure, HIV Infection, Occupational Exposure. Truvada may also be used for purposes not listed in this medication guide. |
||||||||||||||||||||||||
More about Zidovudine | More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | More about Truvada (emtricitabine / tenofovir) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Zidovudine has an average rating of 0.0 out of 10 from a total of 1 ratings on Drugs.com. |
Biktarvy has an average rating of 7.1 out of 10 from a total of 200 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 21% reported a negative effect. |
Truvada has an average rating of 6.3 out of 10 from a total of 37 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 31% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: zidovudine side effects in more detail. |
See also: Biktarvy side effects in more detail. |
See also: Truvada side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all zidovudine prices |
View all Biktarvy prices |
View all Truvada prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Retrovir |
N/A |
Other emtricitabine / tenofovir brands include: AccessPak for HIV PEP Basic | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
1 hour |
180 hours |
25.7 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 354 drugs are known to interact with zidovudine:
|
A total of 423 drugs are known to interact with Biktarvy:
|
A total of 234 drugs are known to interact with Truvada:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
March 19, 1987 |
February 07, 2018 |
August 02, 2004 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.